Publication Cover
Structural Heart
The Journal of the Heart Team
Volume 3, 2019 - Issue 5
62
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Reverse Left Ventricular Remodeling after Surgery in Primary Mitral Regurgitation: A Volume-Related Phased Process

, MD, PhDORCID Icon, , MD, , MD, , MS, , MD, , MD & , MD show all
Pages 383-390 | Received 08 Dec 2018, Accepted 15 May 2019, Published online: 12 Aug 2019
 

ABSTRACT

Background: The short and long-term effects of volume overload elimination on left ventricular (LV) volumetric reverse-remodeling and systemic hemodynamic after surgery for chronic primary mitral regurgitation (MR) have been poorly explored.

Methods: 224 patients (64 ± 13 years) with primary MR underwent serial MR and LV volumetric measurements at baseline, early (5[4–6] days) and late (428 [355–688] days) after surgery.

Results: Early after surgery, the drop in LV end-diastolic volume (EDV index: 119 ± 25 to 75 ± 14 mL/m2, P < 0.0001) was tightly related to pre-operative regurgitant volume (RVol; r = 0.88, P < 0.0001) while end-systolic volume (ESV) index did not change. Although LV ejection fraction (EF) decreased (71 ± 8 to 54 ± 12%, P < 0.0001), forward stroke volume was maintained (P = 0.28). Patients with greater RVol experienced a greater decrease in EDV and LVEF. Later, ESV index decreased (P < 0.0001), EDV index decreased further and LVEF improved to 60 ± 8% (P < 0.0001). Finally, systemic vascular function changes were characterized by an improvement in resistance and compliance.

Conclusion: LV volumetric reverse-remodeling after surgery for primary MR is a phased process. The initial response is driven essentially by elimination of MR with a greater decline in EF in patients with larger RVol. In the late phase LV systolic function improvement is generally observed. Overall, the degree of LV reverse-remodeling is related to the magnitude of RVol, which predicts the early decline in EDV. Finally, LV reverse-remodeling is associated to systemic vascular function remodeling.

Disclosure statement

None of the authors have any conflict of interest to disclose

Additional information

Funding

Thierry le Tourneau was supported by a grant of the French Federation of Cardiology, Paris, France.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.